cognitive cybersecurity intelligence

News and Analysis

Search

FDA widens advisory on eye products after patients blinded, hospitalized

The Food and Drug Administration (FDA) on Tuesday widened an advisory on artificial tear products to include additional ones manufactured by Global Pharma Healthcare Private Limited over concerns of a potential bacterial contamination that could result in blindness or death.

The FDA…

Source: thehill.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts